How we work

Open innovation work environment 
We create an open innovation work environment where professionals come together to share ideas, expertise and visions, inspire each other, and innovate together. In the biobased Pilot plant we have shared offices and works spaces to stimulate collaboration. In the Biomedical facilities, the offices, lab areas and high-end equipment, are set up to be shared and match our desired conditions. This enables our partners to pick-and-choose their facility, by choosing lab rooms, equipment and expertise. 

InSciTe is structured around 4 pillars, the 4 E's
The Expertise pillar rest on our biomedical and biobased projects. A project starts with a proven concept and we form a well-balanced consortium with experts and entrepreneurs that will work together to produce the optimal result. Together, we strive towards delivering a market-ready product or service at the end of the project that will enable business development and commercialization. In our Biomedical program we work according to our Biomedical Accelerator Matrix philosophy. Read here more about this. 

Our Education & Training pillar, is a program which offers a variety of courses, from IP guidelines till LCA training. This program is set up to maximize knowledge and expertise with an entrepreneurial mindset.

As part of our Experimentation pillar we offer a variety of services to enable start-up companies to rent out parts of our facilities.

Our last pillar, Entrepreneurship, we demonstrate that everything that we do needs to be applicable to the market. Both our research and educational programs are geared towards making an economic impact.

You can find more information about the 4 E's here.

 

Intellectual property
To support the commercial objective of a Biomedical or Biobased project, we protect the intellectual property (IP) resulting from its RT&D activities and promote its use in a clinical and industrial setting. A clear set of IP-guidelines has been developed accordingly.

The basic IP guidelines of InSciTe can be summarized as follows:

  • The InSciTe IP guidelines are binding for all participants in InSciTe projects;
  • Foreground IP is owned by the inventing party (‘ownership follows inventorship’)
  • Ownership of background IP will remain with the party contributing the background IP;
  • Participants will have access to background IP listed in an annex to the project agreement, and foreground IP if needed for the purpose and duration of the project;
  • Whenever background IP of another participant is needed for the commercialization of foreground IP, the participants will negotiate the terms of an agreement in good faith;
  • Access rights to foreground IP shall be granted to the other participants for research use for the duration of the project;
  • Access rights to foreground IP after the project has ended will be agreed at the end of the project on a case-by-case basis;
  • Publication and confidentiality of foreground IP must comply with regulations agreed in the IP guidelines;
  • IP-revenue sharing between the participants, including third parties, if any, will be based on their pro rata financial cash and in-kind contribution to the project;
  • Agreement on IP revenue-sharing will be valid as long as revenues are being generated, e.g. for the duration of a license agreement on the basis of IP generated in the project. In many cases this may be considerably longer than the duration of the project;
  • Before the start of each project in InSciTe, a Participants Representative must be appointed. The Participants Representative is exclusively responsible for developing a patenting and commercialization strategy in cooperation with the other project participants, for seeking interested parties for the commercialization, and for managing, filing, prosecuting, and maintaining patent rights;
  • IP gross revenues will be collected and distributed by the Participants Representative;
  • Participation of InSciTe and/or its founding institutes in subsidy programs such as H2020 may necessitate the adjustment of the IP guidelines to fulfil the subsidy and additional subsidy requirements.

We will adhere to the Netherlands Code of Conduct for Scientific Practice (Nederlandse Gedragscode Wetenschapsbeoefening), a code of conduct for academic practice that is generally accepted within academia (VSNU [Association of Universities in the Netherlands], KNAW [Royal Netherlands Academy of Arts and Sciences], NOW [Netherlands Organization for Scientific Research]).

Beneath you can download the InSciTe IP guidelines and the Netherlands Code of Conduct for Scientific Practice.
 

Chemelot InSciTe